BioSpace News Archive

Business

Ablynx Appoints Dr. Robert Friesen as CSO

Dr Friesen has more than 20 years of experience in the biopharmaceutical industry, leading multiple Research and Development (R&D) organisations.

January 24, 2018
·
3 min read
Drug Development

Abstract Outlining Pre-Hospital Stroke Study With Diffusion Pharmaceuticals’ TSC To Be Presented at the International Stroke Conference

The abstract introduces the design and rationale for the planned Phase 2 PHAST-TSC study.

January 24, 2018
·
6 min read
Bio NC

First Patient Enrolled in Tryton Post Approval Study

Tryton today announced that the first patient has been enrolled in the post approval study to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.

January 24, 2018
·
2 min read
Business

Anika Therapeutics Expands Strategic Collaboration with the Institute for Applied Life Sciences (IALS) at the University of Massachusetts Amherst to Develop Innovative Therapy for Rheumatoid Arthritis

In the next phase of this collaboration, Anika and UMass will focus on research to optimize the drug delivery system with the goal of advancing a novel therapeutic candidate into clinical trials to support regulatory submission.

January 24, 2018
·
6 min read
Covalon Announces Issuance of 60,000 Stock Options

The stock options will vest over three years and will be exercisable for a period of five years at an exercise price of $6.02 per stock option.

January 24, 2018
·
2 min read
Drug Development

Generon Successfully Concludes First Phase III Clinical Trial of F-627 for Chemotherapy-Induced Neutropenia

Patients treated with F-627 demonstrated significantly reduced duration of severe neutropenia compared to patents in placebo group (P<0.0001).

January 24, 2018
·
3 min read
Genetown

Partners Connected Health and Vital USA Team Up to Validate the First 5-in-1 Integrated Vital Sign Measurement Tool

Recognizing the movement of increased patient engagement in healthcare, Vital USA has teamed up with the Partners Connected Health team to validate its Vital Moto Mod health and wellness device, a 5-in-1 integrated vital sign monitoring platform.

January 24, 2018
·
3 min read
Immuron to Receive $2.16M R&D Tax Concession Refund

This refund reflects the more than $4.6M investment the Company made in its research and development programs during the 2017.

January 24, 2018
·
3 min read
Business

Rapid Novor Launches REmAb Antibody Protein Sequencing Services on Science Exchange

Science Exchange announced a partnership with Rapid Novor to offer its REmAb Antibody Protein Sequencing Services to scientists around the world using Science Exchange’s R&D platform.

January 24, 2018
·
3 min read
Policy

Colorado BioScience Association Highlights Medtech Disruption

Colorado BioScience Association (CBSA) will host more than 80 medtech leaders to discuss industry metrics, shifting business models, M&A trends, FDA reform and the efforts to seek a permanent repeal of the medical device excise tax during the 2018 CBSA Medical Device Symposium.

January 24, 2018
·
3 min read